These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7220158)

  • 61. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
    Tanphaichitr A; Kusuwan T; Limviriyakul S; Atipas S; Pooliam J; Sangpraypan T; Tanphaichitr VS; Viprakasit V
    Hemoglobin; 2014; 38(5):345-50. PubMed ID: 25051423
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of chelation therapy on cardiac function improvement in thalassemia patients: literature review and the Taiwanese experience.
    Peng CT; Tsai CH; Wu KH
    Hemoglobin; 2008; 32(1-2):49-62. PubMed ID: 18274983
    [TBL] [Abstract][Full Text] [Related]  

  • 63. T2* magnetic resonance: iron and gold.
    Pennell DJ
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):579-81. PubMed ID: 19356484
    [No Abstract]   [Full Text] [Related]  

  • 64. [Curative effects and safety of deferasirox in treatment of iron overload in children with β-thalassemia major].
    Gao HY; Li Q; Chen JJ; Chen GF; Li CG
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Jul; 13(7):531-4. PubMed ID: 21752315
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Mediterranean anemia and the cardiovascular system].
    Malavasi A; Di Girolamo G
    Cardiologia; 1997 Mar; 42(3):245-55. PubMed ID: 9172931
    [No Abstract]   [Full Text] [Related]  

  • 66. Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.
    Taher AT; Temraz S; Cappellini MD
    Expert Rev Hematol; 2013 Oct; 6(5):495-509. PubMed ID: 24083402
    [TBL] [Abstract][Full Text] [Related]  

  • 67. T2* magnetic resonance and myocardial iron in thalassemia.
    Pennell DJ
    Ann N Y Acad Sci; 2005; 1054():373-8. PubMed ID: 16339685
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration.
    Berdoukas V; Dakin C; Freema A; Fraser I; Aessopos A; Bohane T
    Haematologica; 2005 May; 90(5):685-6. PubMed ID: 15921384
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glucose tolerance and chelation therapy in patients with thalassaemia major.
    Capra L; Atti G; De Sanctis V; Candini G
    Haematologica; 1983; 68(1):63-8. PubMed ID: 6404709
    [No Abstract]   [Full Text] [Related]  

  • 70. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
    Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A
    Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Respiratory function tests in adolescents with beta-thalassemia major (author's transl)].
    Secchi GC; Scotti PG; Cambiaghi G; Aresini G; De Carli A; Guerrieri MC
    Haematologica; 1982 Feb; 67(1):23-32. PubMed ID: 6800901
    [No Abstract]   [Full Text] [Related]  

  • 72. [Cardiac dysfunction in children with thalassemia major].
    Angelika L; Graf N; Hoffmann W
    Klin Padiatr; 1988; 200(2):102-7. PubMed ID: 3386182
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan.
    Wang LY; Liang DC; Liu HC; Chang FC; Wang CL; Chan YS; Lin M
    Transfus Med; 2006 Jun; 16(3):200-3. PubMed ID: 16764599
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathogenetic mechanisms in hepatic cirrhosis of thalassemia major: light and electron microscopic studies.
    Iancu TC; Landing BH; Neustein HB
    Pathol Annu; 1977; 12 Pt 1():171-200. PubMed ID: 917591
    [No Abstract]   [Full Text] [Related]  

  • 76. [Monitoring and appraisal of the effects of blood transfusion and iron chelation in thalassemia major].
    Girot R; Triadou P; Bories D; Jeannel F; Thevenin M; Rymer JC
    Nouv Rev Fr Hematol (1978); 1982; 24(5):281-7. PubMed ID: 7167380
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Left ventricular non-compaction in identical twins with thalassaemia and cardiac iron overload.
    Luckie M; Irwin B; Nair S; Greenwood J; Khattar R
    Eur J Echocardiogr; 2009 Jun; 10(4):509-12. PubMed ID: 19091793
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proceedings of the 15th International Conference on Oral Chelation (ICOC) in the Treatment of Thalassemia and Other Diseases. Part 1. Taichung, Taiwan. April 22-26, 2005.
    Hemoglobin; 2006; 30(1):63-137. PubMed ID: 16764044
    [No Abstract]   [Full Text] [Related]  

  • 79. Oral iron chelating drugs: coming but not yet ready for clinical use.
    Hershko C
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1081-2. PubMed ID: 3132216
    [No Abstract]   [Full Text] [Related]  

  • 80. [Thalassemic heart].
    Sadikario A; Doneva V; Mladenovski B; Grivceva N
    God Zb Med Fak Skopje; 1968; 14():200-7. PubMed ID: 5192691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.